Anna Karoline Fausto da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Karoline Fausto da Silva has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Karin Soares Cunha
Graduate Program in Pathology, School of Medicine, Universidade Federal Fluminense, Niterói, Brazil
5 shared publications - Eliane Pedra Dias
Medical School, Fluminense Federal University, Rio de Janeiro, Brazil
4 shared publications - Flávio Barbosa Luz
Department of Dermatology, Hospital Universitário Antonio Pedro, Universidade Federal Fluminense, Niteroi, RJ, Brazil
4 shared publications - Luciana Pantaleão
Fluminense Federal University, Niteroi, Rio de Janeiro, Brazil
4 shared publications - Mayra Carrijo Rochael
Department of Pathology, Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, RJ, Brazil
4 shared publications - Rafael Brandão Varella
Universidade Federal Fluminense, Brazil
4 shared publications
Latest Publications
- Open Access
- 1 September 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (5) , 688-695
Presença de DNA de poliomavírus de células de Merkel e antígeno T‐large em carcinomas de queratinócitos e sua correlação com os marcadores imuno‐histoquímicos p16, p53 e ki67
- 1 September 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (5) , 688-695
Open AccessPresença de DNA de poliomavírus de células de Merkel e antígeno T‐large em carcinomas de queratinócitos e sua correlação com os marcadores imuno‐histoquímicos p16, p53 e ki67
- Open Access
- 29 March 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (5) , 688-695
Presence of Merkel cell polyomavirus DNA and large-T antigen in keratinocyte carcinomas and its correlation with immunohistochemical markers p16, p53 and ki67
- 29 March 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (5) , 688-695
Open AccessPresence of Merkel cell polyomavirus DNA and large-T antigen in keratinocyte carcinomas and its correlation with immunohistochemical markers p16, p53 and ki67
- Open Access
- 1 November 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 98 (6) , 737-749
Poliomavírus de células de Merkel e sua relação etiológica com tumores cutâneos
- 1 November 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 98 (6) , 737-749
Open AccessPoliomavírus de células de Merkel e sua relação etiológica com tumores cutâneos
- Open Access
- 3 July 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (6) , 737-749
Merkel cell polyomavirus and its etiological relationship with skin tumors
- 3 July 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 98 (6) , 737-749
Open AccessMerkel cell polyomavirus and its etiological relationship with skin tumors
- 19 January 2021
- Published by Springer Nature in Virchows Archiv
- Vol. 479 (1) , 121-131
A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues
The Ki-67 labeling index is traditionally used to investigate tumor aggressiveness. However, no diagnostic or prognostic value has been associated to the heterogeneous pattern of nuclear positivity. The aims of this study were to develop a classification for the patterns of Ki-67-positive nuclei; to search scientific evidence for the Ki-67 expression and location throughout the cell cycle; and to develop a protocol to apply the classification of patterns of Ki-67-positive nuclei in squamous epithelium with different proliferative activities. Based on empirical observation of paraffin sections submitted to immunohistochemistry for the determination of Ki-67 labeling index and literature review about Ki-67 expression, we created a classification of the patterns of nuclear positivity (NP1, NP2, NP3, NP4, and mitosis). A semi-automatic protocol was developed to identify and quantify the Ki-67 immunostaining patterns in target tissues. Two observers evaluated 7000 nuclei twice to test the intraobserver reliability, and six evaluated 1000 nuclei to the interobserver evaluation. The results showed that the immunohistochemical patterns of Ki-67 are similar in the tumoral and non-tumoral epithelium and were classified without difficulty. There was a high intraobserver reliability (Spearman correlation coefficient > 0.9) and moderate interobserver agreement (k = 0.523). Statistical analysis showed that non-malignant epithelial specimens presented a higher number of NP1 (geographic tongue = 83.8 ± 21.8; no lesion = 107.6 ± 52.7; and mild dysplasia = 86.6 ± 25.8) when compared to carcinoma in Situ (46.8 ± 34.8) and invasive carcinoma (72.6 ± 37.9). The statistical evaluation showed significant difference (p < 0.05). Thus, we propose a new way to evaluate Ki-67, where the pattern of its expression may be associated with the dynamics of the cell cycle. Future proof of this association will validate the use of the classification for its possible impact on cancer prognosis and guidance on personalized therapy.
- 19 January 2021
- Published by Springer Nature in Virchows Archiv
- Vol. 479 (1) , 121-131
A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues
The Ki-67 labeling index is traditionally used to investigate tumor aggressiveness. However, no diagnostic or prognostic value has been associated to the heterogeneous pattern of nuclear positivity. The aims of this study were to develop a classification for the patterns of Ki-67-positive nuclei; to search scientific evidence for the Ki-67 expression and location throughout the cell cycle; and to develop a protocol to apply the classification of patterns of Ki-67-positive nuclei in squamous epithelium with different proliferative activities. Based on empirical observation of paraffin sections submitted to immunohistochemistry for the determination of Ki-67 labeling index and literature review about Ki-67 expression, we created a classification of the patterns of nuclear positivity (NP1, NP2, NP3, NP4, and mitosis). A semi-automatic protocol was developed to identify and quantify the Ki-67 immunostaining patterns in target tissues. Two observers evaluated 7000 nuclei twice to test the intraobserver reliability, and six evaluated 1000 nuclei to the interobserver evaluation. The results showed that the immunohistochemical patterns of Ki-67 are similar in the tumoral and non-tumoral epithelium and were classified without difficulty. There was a high intraobserver reliability (Spearman correlation coefficient > 0.9) and moderate interobserver agreement (k = 0.523). Statistical analysis showed that non-malignant epithelial specimens presented a higher number of NP1 (geographic tongue = 83.8 ± 21.8; no lesion = 107.6 ± 52.7; and mild dysplasia = 86.6 ± 25.8) when compared to carcinoma in Situ (46.8 ± 34.8) and invasive carcinoma (72.6 ± 37.9). The statistical evaluation showed significant difference (p < 0.05). Thus, we propose a new way to evaluate Ki-67, where the pattern of its expression may be associated with the dynamics of the cell cycle. Future proof of this association will validate the use of the classification for its possible impact on cancer prognosis and guidance on personalized therapy.
- Open Access
- 7 November 2019
- Published by Wiley in Stem Cells International
- Vol. 2019, 1-17
The Manufacture of GMP-Grade Bone Marrow Stromal Cells with Validated In Vivo Bone-Forming Potential in an Orthopedic Clinical Center in Brazil
In vitro-expanded bone marrow stromal cells (BMSCs) have long been proposed for the treatment of complex bone-related injuries because of their inherent potential to differentiate into multiple skeletal cell types, modulate inflammatory responses, and support angiogenesis. Although a wide variety of methods have been used to expand BMSCs on a large scale by using good manufacturing practice (GMP), little attention has been paid to whether the expansion procedures indeed allow the maintenance of critical cell characteristics and potency, which are crucial for therapeutic effectiveness. Here, we described standard procedures adopted in our facility for the manufacture of clinical-grade BMSC products with a preserved capacity to generate bone in vivo in compliance with the Brazilian regulatory guidelines for cells intended for use in humans. Bone marrow samples were obtained from trabecular bone. After cell isolation in standard monolayer flasks, BMSC expansion was subsequently performed in two cycles, in 2- and 10-layer cell factories, respectively. The average cell yield per cell factory at passage 1 was of cells, while at passage 2, it was of cells. All final cellular products were free from contamination with aerobic/anaerobic pathogens, mycoplasma, and bacterial endotoxins. The expanded BMSCs expressed CD73, CD90, CD105, and CD146 and were able to differentiate into osteogenic, chondrogenic, and adipogenic lineages in vitro. Most importantly, nine out of 10 of the cell products formed bone when transplanted in vivo. These validated procedures will serve as the basis for in-house BMSC manufacturing for use in clinical applications in our center.- 7 November 2019
- Published by Wiley in Stem Cells International
- Vol. 2019, 1-17
Open AccessThe Manufacture of GMP-Grade Bone Marrow Stromal Cells with Validated In Vivo Bone-Forming Potential in an Orthopedic Clinical Center in Brazil
In vitro-expanded bone marrow stromal cells (BMSCs) have long been proposed for the treatment of complex bone-related injuries because of their inherent potential to differentiate into multiple skeletal cell types, modulate inflammatory responses, and support angiogenesis. Although a wide variety of methods have been used to expand BMSCs on a large scale by using good manufacturing practice (GMP), little attention has been paid to whether the expansion procedures indeed allow the maintenance of critical cell characteristics and potency, which are crucial for therapeutic effectiveness. Here, we described standard procedures adopted in our facility for the manufacture of clinical-grade BMSC products with a preserved capacity to generate bone in vivo in compliance with the Brazilian regulatory guidelines for cells intended for use in humans. Bone marrow samples were obtained from trabecular bone. After cell isolation in standard monolayer flasks, BMSC expansion was subsequently performed in two cycles, in 2- and 10-layer cell factories, respectively. The average cell yield per cell factory at passage 1 was of cells, while at passage 2, it was of cells. All final cellular products were free from contamination with aerobic/anaerobic pathogens, mycoplasma, and bacterial endotoxins. The expanded BMSCs expressed CD73, CD90, CD105, and CD146 and were able to differentiate into osteogenic, chondrogenic, and adipogenic lineages in vitro. Most importantly, nine out of 10 of the cell products formed bone when transplanted in vivo. These validated procedures will serve as the basis for in-house BMSC manufacturing for use in clinical applications in our center. - Open Access
- 1 November 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 94 (6) , 677-683
Investigação da via Th17 na psoríase e na língua geográfica
- 1 November 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 94 (6) , 677-683
Open AccessInvestigação da via Th17 na psoríase e na língua geográfica
- Open Access
- 1 November 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 94 (6) , 677-683
Evaluation of the Th17 pathway in psoriasis and geographic tongue
- 1 November 2019
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 94 (6) , 677-683
Open AccessEvaluation of the Th17 pathway in psoriasis and geographic tongue
- 24 September 2019
- Published by Springer Nature in Head and Neck Pathology
- Vol. 14 (3) , 598-605
Computerized Evaluation of the Immunoexpression of Ki-67 Protein in Odontogenic Keratocyst and Dentigerous Cyst
Evaluation and comparison of odontogenic keratocysts and detigerous cysts immunoexpression and immunostaining intensities of Ki-67 antigen by assessing the whole extent of the epithelium (all epithelium layers in combination) and each layer individually. Ki-67 immunoexpression was evaluated in 15 odontogenic keratocysts and 6 dentigerous cysts using automated methods and the Aperio Technologies Inc. computer system. No statistically significant differences were observed in immunoexpression nor in immunostaining intensities between both lesions. Also, no statistically significant differences were found between odontogenic keratocysts from maxilla versus mandible nor primary versus recurrent. However, odontogenic keratocyst showed a significantly higher cellular proliferation index in the suprabasal layers compared to the basal layer. Assessment of the cellular proliferation index through a computerized system enabled the evaluation of all epithelial tissue without field selection. The increased Ki-67 immunoexpression in suprabasal layers of odontogenic keratocyst suggests a different biological behavior and more aggressive proliferation potential when compared to dentigerous cyst. The same result was found in recurrent odontogenic keratocysts when compared with primary ones. The odontogenic keratocysts of the maxilla and mandible have similar Ki-67 immunoexpression. The evaluation of cellular proliferation only by immunohistochemical analysis with Ki-67 antigen does not provide enough data to elucidate the biological behavior of odontogenic keratocyst.
- 24 September 2019
- Published by Springer Nature in Head and Neck Pathology
- Vol. 14 (3) , 598-605
Computerized Evaluation of the Immunoexpression of Ki-67 Protein in Odontogenic Keratocyst and Dentigerous Cyst
Evaluation and comparison of odontogenic keratocysts and detigerous cysts immunoexpression and immunostaining intensities of Ki-67 antigen by assessing the whole extent of the epithelium (all epithelium layers in combination) and each layer individually. Ki-67 immunoexpression was evaluated in 15 odontogenic keratocysts and 6 dentigerous cysts using automated methods and the Aperio Technologies Inc. computer system. No statistically significant differences were observed in immunoexpression nor in immunostaining intensities between both lesions. Also, no statistically significant differences were found between odontogenic keratocysts from maxilla versus mandible nor primary versus recurrent. However, odontogenic keratocyst showed a significantly higher cellular proliferation index in the suprabasal layers compared to the basal layer. Assessment of the cellular proliferation index through a computerized system enabled the evaluation of all epithelial tissue without field selection. The increased Ki-67 immunoexpression in suprabasal layers of odontogenic keratocyst suggests a different biological behavior and more aggressive proliferation potential when compared to dentigerous cyst. The same result was found in recurrent odontogenic keratocysts when compared with primary ones. The odontogenic keratocysts of the maxilla and mandible have similar Ki-67 immunoexpression. The evaluation of cellular proliferation only by immunohistochemical analysis with Ki-67 antigen does not provide enough data to elucidate the biological behavior of odontogenic keratocyst.
- 10 January 2018
- Published by Wiley in International Journal of Dermatology
- Vol. 57 (2) , 209-216
Evaluation of ICAM‐1 expression and vascular changes in the skin of patients with plaque, pustular, and erythrodermic psoriasis
Background: Psoriasis is a chronic inflammatory disease. Pustular, erythrodermic, and extensive plaque psoriasis are responsible for systemic complications. Systemic capillary leak syndrome is the complication with greater progression to death and occurs due to vascular changes.Purpose: The aim of this study was to evaluate vascular changes through the expression of CD34 and ICAM‐1 in plaque, pustular, and erythrodermic psoriasis.Methods: The sample consisted of seven patients with erythrodermic psoriasis, 24 with moderate‐severe plaque psoriasis, 14 with mild plaque psoriasis and 13 with pustular psoriasis. Patients were submitted to physical examination and skin biopsy for histopathological examination and immunohistochemical analysis with anti‐CD34 and anti‐ICAM‐1 antibodies. Subsequently, tissue fragments were organized by groups using the Tissue Macroarray (TMA) technique to perform immunohistochemistry.Results: In 58 patients, analysis of vessels using anti‐CD34 demonstrated vascular immunostaining in superficial dermis and between dermal papillae. There were more blood vessels in erythrodermic psoriasis, followed by plaque psoriasis. In erythrodermic psoriasis, there were small and few tortuous blood vessels with great dilatation, while plaque psoriasis presented larger vessels that were less dilated and more tortuous. There was an intense and localized expression of ICAM‐1 in endothelial and lymphocytic cells in all groups, with significant differences.Conclusions: Vascular alterations are important in psoriasis, with an increase in the number of blood vessels and ICAM‐1 overexpression, especially in erythrodermic form. Therefore, vascular changes and the expression of intercellular adhesion molecules could help to diagnose the erythrodermic form of psoriasis.
- 10 January 2018
- Published by Wiley in International Journal of Dermatology
- Vol. 57 (2) , 209-216
Evaluation of ICAM‐1 expression and vascular changes in the skin of patients with plaque, pustular, and erythrodermic psoriasis
Background: Psoriasis is a chronic inflammatory disease. Pustular, erythrodermic, and extensive plaque psoriasis are responsible for systemic complications. Systemic capillary leak syndrome is the complication with greater progression to death and occurs due to vascular changes.Purpose: The aim of this study was to evaluate vascular changes through the expression of CD34 and ICAM‐1 in plaque, pustular, and erythrodermic psoriasis.Methods: The sample consisted of seven patients with erythrodermic psoriasis, 24 with moderate‐severe plaque psoriasis, 14 with mild plaque psoriasis and 13 with pustular psoriasis. Patients were submitted to physical examination and skin biopsy for histopathological examination and immunohistochemical analysis with anti‐CD34 and anti‐ICAM‐1 antibodies. Subsequently, tissue fragments were organized by groups using the Tissue Macroarray (TMA) technique to perform immunohistochemistry.Results: In 58 patients, analysis of vessels using anti‐CD34 demonstrated vascular immunostaining in superficial dermis and between dermal papillae. There were more blood vessels in erythrodermic psoriasis, followed by plaque psoriasis. In erythrodermic psoriasis, there were small and few tortuous blood vessels with great dilatation, while plaque psoriasis presented larger vessels that were less dilated and more tortuous. There was an intense and localized expression of ICAM‐1 in endothelial and lymphocytic cells in all groups, with significant differences.Conclusions: Vascular alterations are important in psoriasis, with an increase in the number of blood vessels and ICAM‐1 overexpression, especially in erythrodermic form. Therefore, vascular changes and the expression of intercellular adhesion molecules could help to diagnose the erythrodermic form of psoriasis.